ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....
ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....
On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....
On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....
On July 31, 2025, QuantWave, an automated forecasting platform, issued a long signal for ASTRAZENECA PLC when the stock was trading at $72.59....
ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.64%. The forecast signal was issued on August 8, 2025, with the stock priced at $73....
ASTRAZENECA PLC stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 12.34%. The forecast signal was generated on August 6, 2025, with a price of $73....
On July 14, 2025, QuantWave, the automated forecasting platform, issued a signal to go long on AstraZeneca PLC with a price of $71.24....
AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....
On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....
On January 2, 2024, QuantWave's forecast signal for ASTRAZENECA PLC (AZN) indicated a long position with a price of $65.55. Today, on April 25, 2024, the stock reached the predicted target price of $73....
AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....
AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....
AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....
AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....